Literature DB >> 6252156

Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study.

H Lode, B Kemmerich, G Gruhlke, G Dzwillo, P Koeppe, I Wagner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6252156     DOI： 10.1093/jac/6.suppl_a.193

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  11 in total

Review 1.  Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.

Authors:  Rina Mehrotra; Raffaele De Gaudio; Mark Palazzo
Journal:  Intensive Care Med       Date:  2004-11-05       Impact factor: 17.440

Review 2.  Drug treatment of pneumonia in the hospital. What are the choices?

Authors:  M Aoun; J Klastersky
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

3.  Penetration of cefotaxime into respiratory secretions.

Authors:  R B Fick; M R Alexander; R A Prince; J E Kasik
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

4.  [Therapy with cefotaxime-cefotaxime/ticarcillin for bronchopulmonary infections in patients under intensive care. (author's transl)].

Authors:  C D Schwigon
Journal:  Infection       Date:  1982       Impact factor: 3.553

5.  Pharmacokinetics of cefoxitin administered by i.v. infusion to patients with a pleural effusion.

Authors:  M J Otero; M J Garcia; M Barrueco; A Dominguez-Gil; F Gomez; J Portugal Alvarez
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  The pharmacokinetics of new cephalosporins: significance in clinical practice.

Authors:  H C Neu
Journal:  Bull N Y Acad Med       Date:  1984-05

Review 7.  Treatment of respiratory tract infections with cephalosporin antibiotics.

Authors:  R Finch
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.

Authors:  H Lode; P D Glatzel
Journal:  Infection       Date:  1985       Impact factor: 3.553

9.  Disposition of phosphomycin in patients with pleural effusion.

Authors:  C F Lastra; E L Mariño; M Barrueco; M S Gervós; A D Gil
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

10.  Study on the binding behavior of lysozyme with cephalosporin analogues by fluorescence spectroscopy.

Authors:  Zhuming Wang; Xijuan Tan; Donghua Chen; Qiaoli Yue; Zhenghua Song
Journal:  J Fluoresc       Date:  2009-04-03       Impact factor: 2.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.